PD-0325901
To Order Contact us: lieven@wlsolutions.be
PD 0325901 |
||
GL5463-25 | 25 | EUR 228.1 |
PD 0325901 |
||
GL5463-5 | 5 | EUR 98.4 |
EZSolution? PD-0325901, Sterile-Filtered |
||
1990-1 | each | EUR 326.4 |
PD 312236, PD 312237 Mixture |
||
P217850 | 10mg | EUR 230 |
PD-1/PD-L1 inhibitor 2 |
||
B6023-25 | 25 mg | EUR 268 |
Description: PD-1/PD-L1 interaction inhibitor |
PD-1/PD-L1 inhibitor 2 |
||
B6023-5 | 5 mg | EUR 84 |
Description: PD-1/PD-L1 interaction inhibitor |
PD-1/PD-L1 inhibitor 1 |
||
B6172-25 | 25 mg | EUR 278 |
Description: PD-1/PD-L1 interaction inhibitor |
PD-1/PD-L1 inhibitor 1 |
||
B6172-5 | 5 mg | EUR 82 |
Description: PD-1/PD-L1 interaction inhibitor |
PD-1/PD-L1 Inhibitor 3 |
||
B6191-1 | 1 mg | EUR 249 |
Description: PD-1/PD-L1 interaction inhibitor |
PD-1/PD-L1 Inhibitor 3 |
||
B6191-5 | 5 mg | EUR 838 |
Description: PD-1/PD-L1 interaction inhibitor |
PD-1/PD-L1 Inhibitor 2 |
||
B1050-25 | each | EUR 679.2 |
PD-1/PD-L1 Inhibitor 2 |
||
B1050-5 | each | EUR 242.4 |
PD-1/PD-L1 Inhibitor 1 |
||
B1213-25 | each | EUR 679.2 |
PD-1/PD-L1-IN-NP19 |
||
T36900-10mg | 10mg | Ask for price |
Description: PD-1/PD-L1-IN-NP19 |
PD-1/PD-L1-IN-NP19 |
||
T36900-1g | 1g | Ask for price |
Description: PD-1/PD-L1-IN-NP19 |
PD-1/PD-L1-IN-NP19 |
||
T36900-1mg | 1mg | Ask for price |
Description: PD-1/PD-L1-IN-NP19 |
PD-1/PD-L1-IN-NP19 |
||
T36900-50mg | 50mg | Ask for price |
Description: PD-1/PD-L1-IN-NP19 |
PD-1/PD-L1-IN-NP19 |
||
T36900-5mg | 5mg | Ask for price |
Description: PD-1/PD-L1-IN-NP19 |
PD-1/PD-L1-IN-22 |
||
T63607-10mg | 10mg | Ask for price |
Description: PD-1/PD-L1-IN-22 |
PD-1/PD-L1-IN-22 |
||
T63607-1g | 1g | Ask for price |
Description: PD-1/PD-L1-IN-22 |
PD-1/PD-L1-IN-22 |
||
T63607-1mg | 1mg | Ask for price |
Description: PD-1/PD-L1-IN-22 |
PD-1/PD-L1-IN-22 |
||
T63607-50mg | 50mg | Ask for price |
Description: PD-1/PD-L1-IN-22 |
PD-1/PD-L1-IN-22 |
||
T63607-5mg | 5mg | Ask for price |
Description: PD-1/PD-L1-IN-22 |
PD-1/PD-L1-IN-15 |
||
T63614-10mg | 10mg | Ask for price |
Description: PD-1/PD-L1-IN-15 |
PD-1/PD-L1-IN-15 |
||
T63614-1g | 1g | Ask for price |
Description: PD-1/PD-L1-IN-15 |
PD-1/PD-L1-IN-15 |
||
T63614-1mg | 1mg | Ask for price |
Description: PD-1/PD-L1-IN-15 |
PD-1/PD-L1-IN-15 |
||
T63614-50mg | 50mg | Ask for price |
Description: PD-1/PD-L1-IN-15 |
PD-1/PD-L1-IN-15 |
||
T63614-5mg | 5mg | Ask for price |
Description: PD-1/PD-L1-IN-15 |
PD-1/PD-L1-IN-16 |
||
T63948-10mg | 10mg | Ask for price |
Description: PD-1/PD-L1-IN-16 |
PD-1/PD-L1-IN-16 |
||
T63948-1g | 1g | Ask for price |
Description: PD-1/PD-L1-IN-16 |
PD-1/PD-L1-IN-16 |
||
T63948-1mg | 1mg | Ask for price |
Description: PD-1/PD-L1-IN-16 |
PD-1/PD-L1-IN-16 |
||
T63948-50mg | 50mg | Ask for price |
Description: PD-1/PD-L1-IN-16 |
PD-1/PD-L1-IN-16 |
||
T63948-5mg | 5mg | Ask for price |
Description: PD-1/PD-L1-IN-16 |
PD-1/PD-L1-IN-20 |
||
T64086-10mg | 10mg | Ask for price |
Description: PD-1/PD-L1-IN-20 |
PD-1/PD-L1-IN-20 |
||
T64086-1g | 1g | Ask for price |
Description: PD-1/PD-L1-IN-20 |
PD-1/PD-L1-IN-20 |
||
T64086-1mg | 1mg | Ask for price |
Description: PD-1/PD-L1-IN-20 |
PD-1/PD-L1-IN-20 |
||
T64086-50mg | 50mg | Ask for price |
Description: PD-1/PD-L1-IN-20 |
PD-1/PD-L1-IN-20 |
||
T64086-5mg | 5mg | Ask for price |
Description: PD-1/PD-L1-IN-20 |
PD-1/PD-L1-IN-25 |
||
T63329-10mg | 10mg | Ask for price |
Description: PD-1/PD-L1-IN-25 |
PD-1/PD-L1-IN-25 |
||
T63329-1g | 1g | Ask for price |
Description: PD-1/PD-L1-IN-25 |
PD-1/PD-L1-IN-25 |
||
T63329-1mg | 1mg | Ask for price |
Description: PD-1/PD-L1-IN-25 |
PD-1/PD-L1-IN-25 |
||
T63329-50mg | 50mg | Ask for price |
Description: PD-1/PD-L1-IN-25 |
PD-1/PD-L1-IN-25 |
||
T63329-5mg | 5mg | Ask for price |
Description: PD-1/PD-L1-IN-25 |
PD-1/PD-L1-IN-17 |
||
T62501-10mg | 10mg | Ask for price |
Description: PD-1/PD-L1-IN-17 |
PD-1/PD-L1-IN-17 |
||
T62501-1g | 1g | Ask for price |
Description: PD-1/PD-L1-IN-17 |
PD-1/PD-L1-IN-17 |
||
T62501-1mg | 1mg | Ask for price |
Description: PD-1/PD-L1-IN-17 |
PD-1/PD-L1-IN-17 |
||
T62501-50mg | 50mg | Ask for price |
Description: PD-1/PD-L1-IN-17 |
PD-1/PD-L1-IN-17 |
||
T62501-5mg | 5mg | Ask for price |
Description: PD-1/PD-L1-IN-17 |
PD-1/PD-L1-IN-14 |
||
T61929-10mg | 10mg | Ask for price |
Description: PD-1/PD-L1-IN-14 |
PD-1/PD-L1-IN-14 |
||
T61929-1g | 1g | Ask for price |
Description: PD-1/PD-L1-IN-14 |
PD-1/PD-L1-IN-14 |
||
T61929-1mg | 1mg | Ask for price |
Description: PD-1/PD-L1-IN-14 |
PD-1/PD-L1-IN-14 |
||
T61929-50mg | 50mg | Ask for price |
Description: PD-1/PD-L1-IN-14 |
PD-1/PD-L1-IN-14 |
||
T61929-5mg | 5mg | Ask for price |
Description: PD-1/PD-L1-IN-14 |
PD-1/PD-L1-IN 6 |
||
T61968-10mg | 10mg | Ask for price |
Description: PD-1/PD-L1-IN 6 |
PD-1/PD-L1-IN 6 |
||
T61968-1g | 1g | Ask for price |
Description: PD-1/PD-L1-IN 6 |
PD-1/PD-L1-IN 6 |
||
T61968-1mg | 1mg | Ask for price |
Description: PD-1/PD-L1-IN 6 |
PD-1/PD-L1-IN 6 |
||
T61968-50mg | 50mg | Ask for price |
Description: PD-1/PD-L1-IN 6 |
PD-1/PD-L1-IN 6 |
||
T61968-5mg | 5mg | Ask for price |
Description: PD-1/PD-L1-IN 6 |
PD-1/PD-L1-IN 5 |
||
T62193-10mg | 10mg | Ask for price |
Description: PD-1/PD-L1-IN 5 |
PD-1/PD-L1-IN 5 |
||
T62193-1g | 1g | Ask for price |
Description: PD-1/PD-L1-IN 5 |
PD-1/PD-L1-IN 5 |
||
T62193-1mg | 1mg | Ask for price |
Description: PD-1/PD-L1-IN 5 |
PD-1/PD-L1-IN 5 |
||
T62193-50mg | 50mg | Ask for price |
Description: PD-1/PD-L1-IN 5 |
PD-1/PD-L1-IN 5 |
||
T62193-5mg | 5mg | Ask for price |
Description: PD-1/PD-L1-IN 5 |
PD-1/PD-L1-IN-10 |
||
T9616-10mg | 10mg | Ask for price |
Description: PD-1/PD-L1-IN-10 |
PD-1/PD-L1-IN-10 |
||
T9616-1g | 1g | Ask for price |
Description: PD-1/PD-L1-IN-10 |
PD-1/PD-L1-IN-10 |
||
T9616-1mg | 1mg | Ask for price |
Description: PD-1/PD-L1-IN-10 |
PD-1/PD-L1-IN-10 |
||
T9616-50mg | 50mg | Ask for price |
Description: PD-1/PD-L1-IN-10 |
PD-1/PD-L1-IN-10 |
||
T9616-5mg | 5mg | Ask for price |
Description: PD-1/PD-L1-IN-10 |
PD-1/PD-L1-IN-9 |
||
T9651-10mg | 10mg | Ask for price |
Description: PD-1/PD-L1-IN-9 |
PD-1/PD-L1-IN-9 |
||
T9651-1g | 1g | Ask for price |
Description: PD-1/PD-L1-IN-9 |
PD-1/PD-L1-IN-9 |
||
T9651-1mg | 1mg | Ask for price |
Description: PD-1/PD-L1-IN-9 |
PD-1/PD-L1-IN-9 |
||
T9651-50mg | 50mg | Ask for price |
Description: PD-1/PD-L1-IN-9 |
PD-1/PD-L1-IN-9 |
||
T9651-5mg | 5mg | Ask for price |
Description: PD-1/PD-L1-IN-9 |
PD-173212 |
||
598025 | 5.0mg | EUR 375 |
PD-166793 |
||
598116 | 10.0mg | EUR 360 |
PD 98059 |
||
1666-5 | each | EUR 189.6 |
PD 173074 |
||
1675-1 | each | EUR 164.4 |
PD 173074 |
||
1675-100 | each | Ask for price |
PD 150,606 |
||
1906-25 | each | EUR 444 |
PD 150,606 |
||
1906-5 | each | EUR 164.4 |
PD 173074 |
||
27056 | 10 mg | EUR 125 |
Description: PD 173074 inhibited the kinase activity of FGFR1 with an IC50 of 25 nM in vitro, while inhibiting Src, the receptors for insulin, epidermal growth factor (EGF) and PDGF, and several serine/threonine kinases with 1000-fold or higher IC50 values. PD 173074 was an ATP-competitive inhibitor of FGFR1, with a Ki of around 40 nM. PD 173074 inhibited autophosphorylation of FGFR1 and VEGFR2 in a dose-dependent manner with IC50s in the range of 1-5 nM and 100-200 nM, respectively. |
PD-168393 |
||
406105 | 25.0mg | EUR 300 |
PD-173955 |
||
406164 | 25.0mg | EUR 250 |
PD 124966 |
||
414279 | 500.0µg | EUR 355 |
PD 81723 |
||
414815 | 10.0mg | EUR 335 |
PD-161570 |
||
407384 | 5.0mg | EUR 285 |
PD 0332991 |
||
E1KS1116 | 5mg | EUR 482.4 |
PD-L1 |
||
E8ET1701-41 | 100ul | EUR 275 |
Description: Available in various conjugation types. |
PD-ECGF |
||
GT15181 | 100 ug | EUR 631.2 |
PD 082106 |
||
461981 | 5.0mg | EUR 300 |
PD 150606 |
||
A4413-10 | 10mg | EUR 146 |
Description: Non-peptide calpain inhibitor |
PD 150606 |
||
A4413-25 | 25 mg | EUR 304 |
Description: Non-peptide calpain inhibitor |
PD 150606 |
||
A4413-5 | 5 mg | EUR 87 |
Description: Non-peptide calpain inhibitor |
PD 150606 |
||
A4413-50 | 50mg | EUR 542 |
Description: Non-peptide calpain inhibitor |
PD 166793 |
||
A4438-10 | 10 mg | EUR 175 |
Description: MMP inhibitor |
PD 166793 |
||
A4438-25 | 25 mg | EUR 597.6 |
Description: Broad spectrum MMP inhibitor. Displays high affinity for MMP-2, -3 and -13 (IC50 values are 4, 7 and 8 nM respectively) and exhibits > 750-fold selectivity over MMP-1, -7 and -9. Attenuates left ventricular remodelling and dysfunction in rat model of heart failure. |
PD 166793 |
||
A4438-5 | 5 mg | EUR 224.4 |
Description: Broad spectrum MMP inhibitor. Displays high affinity for MMP-2, -3 and -13 (IC50 values are 4, 7 and 8 nM respectively) and exhibits > 750-fold selectivity over MMP-1, -7 and -9. Attenuates left ventricular remodelling and dysfunction in rat model of heart failure. |
PD 166793 |
||
A4438-50 | 50mg | EUR 730 |
Description: MMP inhibitor |
PD 117519 |
||
585228 | 5.0mg | EUR 230 |
PD-118057 |
||
561213 | 5.0mg | EUR 330 |
PD-151746 |
||
563384 | 5.0mg | EUR 280 |
PD 146176 |
||
530393 | 10.0mg | EUR 250 |
PD 150606 |
||
531245 | 200.0mg | EUR 950 |
PD-85639 |
||
531389 | 5.0mg | EUR 250 |
PD-156707 |
||
532448 | 5.0mg | EUR 265 |
PD 158780 |
||
532449 | 10.0mg | EUR 470 |
PD 168368 |
||
532455 | 5.0mg | EUR 350 |
PD-169316 |
||
510236 | 50.0mg | EUR 250 |
PD-166285 |
||
525796 | 5.0mg | EUR 275 |
PD 109488 |
||
525816 | 50.0mg | EUR 1340 |
PD 135158 |
||
525842 | 10.0mg | EUR 390 |
PD-176252 |
||
525902 | 10.0mg | EUR 400 |
PD-198306 |
||
525904 | 5.0mg | EUR 410 |
PD 334581 |
||
B5727-10 | 10 mg | EUR 352 |
Description: MEK1 inhibitor |
PD 334581 |
||
B5727-50 | 50 mg | EUR 1435 |
Description: MEK1 inhibitor |
PD 173212 |
||
B7424-10 | 10 mg | EUR 351 |
Description: N-type voltage-gated calcium channel blocker |
PD 173212 |
||
B7424-2 | 2mg | EUR 133 |
Description: N-type voltage-gated calcium channel blocker |
PD 173212 |
||
B7424-5 | 5 mg | EUR 238 |
Description: N-type voltage-gated calcium channel blocker |
PD 173212 |
||
B7424-5.1 | 10 mM (in 1mL DMSO) | EUR 574.8 |
PD 161570 |
||
B7486-10 | 10 mg | EUR 322 |
Description: FGFR inhibitor |
PD 161570 |
||
B7486-50 | 50 mg | EUR 1322 |
Description: FGFR inhibitor |
PD 169316 |
||
B1703-25 | each | EUR 652.8 |
PD 169316 |
||
B1703-5 | each | EUR 210 |
PD 81723 |
||
B6705-10 | 10 mg | EUR 197 |
Description: Allosteric potentiator at the adenosine A1 receptor |
PD 81723 |
||
B6705-50 | 50 mg | EUR 819 |
Description: Allosteric potentiator at the adenosine A1 receptor |
PD 102807 |
||
B6821-10 | 10 mg | EUR 285 |
Description: M4 muscarinic receptor antagonist |
PD 102807 |
||
B6821-50 | 50 mg | EUR 1163 |
Description: M4 muscarinic receptor antagonist |
PD 160170 |
||
B6972-10 | 10 mg | EUR 408 |
PD 176252 |
||
B7122-10 | 10 mg | EUR 390 |
Description: gastrin-releasing peptide receptor (GRP-R, BB2) and neuromedin B receptor (NMB-R, BB1) antagonist |
PD 198306 |
||
B7124-1 | 1 mg | EUR 151.2 |
Description: IC50: 8 nM for MEK [1]PD 198306 is a potent, selective and non-ATP competitive MAPK/ERK-kinase (MEK) inhibitor. MEK is a kinase enzyme which phosphorylates mitogen-activated protein kinase (MAPK). |
PD 198306 |
||
B7124-10 | 10 mg | EUR 372 |
Description: MEK1/2 inhibitor |
PD 198306 |
||
B7124-5 | 5 mg | EUR 381.6 |
Description: IC50: 8 nM for MEK [1]PD 198306 is a potent, selective and non-ATP competitive MAPK/ERK-kinase (MEK) inhibitor. MEK is a kinase enzyme which phosphorylates mitogen-activated protein kinase (MAPK). |
PD 135158 |
||
B7127-10 | 10 mg | EUR 366 |
Description: CCK2 receptor antagonist |
PD 135158 |
||
B7127-50 | 50 mg | EUR 1506 |
Description: CCK2 receptor antagonist |
PD 158780 |
||
B7130-10 | 10 mg | EUR 143 |
Description: ErbB receptor family tyrosine kinase inhibitor |
PD 158780 |
||
B7130-25 | 25 mg | EUR 543.6 |
PD 158780 |
||
B7130-5 | 5 mg | EUR 181.2 |
PD 158780 |
||
B7130-50 | 50mg | EUR 514 |
Description: ErbB receptor family tyrosine kinase inhibitor |
PD 118057 |
||
B7203-10 | 10 mg | EUR 400.8 |
PD 118057 |
||
B7203-50 | 50 mg | EUR 1491.6 |
PD 146176 |
||
B7208-10 | 10 mg | EUR 180 |
PD 146176 |
||
B7208-25 | 25 mg | EUR 344.4 |
PD 146176 |
||
B7208-5 | 5mg | EUR 463 |
Description: 15-lipoxygenase (15-LOX) inhibitor |
PD 146176 |
||
B7208-50 | 50 mg | EUR 567.6 |
PD 151746 |
||
B4791-100 | 100 mg | EUR 376 |
Description: calpain inhibitor, cell-permeable |
PD 151746 |
||
B4791-25 | 25 mg | EUR 160 |
Description: calpain inhibitor, cell-permeable |
PD 151746 |
||
B4791-5 | 5 mg | EUR 48 |
Description: calpain inhibitor, cell-permeable |
PD 151746 |
||
B4791-5.1 | 10 mM (in 1mL DMSO) | EUR 53 |
Description: calpain inhibitor, cell-permeable |
PD-166866 |
||
B2223-25 | each | EUR 810 |
PD-166866 |
||
B2223-5 | each | EUR 248.4 |
PD-146176 |
||
B2313-25 | each | EUR 810 |
PD-146176 |
||
B2313-5 | each | EUR 248.4 |
PD-168393 |
||
B2352-25 | each | EUR 496.8 |
PD-168393 |
||
B2352-5 | each | EUR 170.4 |
PD 169316 |
||
A8689-10 | 10 mg | EUR 72 |
Description: P38 MAPK inhibitor |
PD 169316 |
||
A8689-5.1 | 10 mM (in 1mL DMSO) | EUR 106 |
Description: P38 MAPK inhibitor |
PD 169316 |
||
A8689-50 | 50 mg | EUR 271 |
Description: P38 MAPK inhibitor |
PD 180970 |
||
A8606-10 | 10 mg | EUR 302 |
Description: P210bcr/abl tyrosine kinase inhibitor |